IP Library › Granted Patent US 11,141,441
Granted Patent B2
US 11,141,441 · App. 17/017,105 · Granted Oct 12, 2021

Microbial hyperswarmers and uses thereof

Inventors: Sridhar Mani (Riverdale, NY); Libusha Kelly (Brooklyn, NY); Hao Li (Elmsford, NY)
Assignee: Albert Einstein College of Medicine
A61K35/744A61K9/48A61K35/741A61K35/742C12N1/20G01N33/483A61K9/0031A61K9/0053A61P1/14Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,441
App. No.
17/017,105
Granted
Oct 12, 2021
Kind
B2
Abstract

Bacterial hyperswarmers are disclosed for treatment, prevention and diagnosis of conditions such as intestinal inflammation.

Claims (2)

1. A composition for treating an intestinal inflammation in a subject, wherein the composition is encapsulated and comprises bacterial hyperswarmers selected from one or more of the group consisting of Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Serratia marcescens, Proteus mirabilis, Acinetobacter sp., Bacillus sp., Enterobacter sp., Enterobacter asburiae, Enterobacter cloacae and Cedecea davisae, wherein the composition of one or more isolated bacterial hyperswarmers is in an amount effective to treat an intestinal inflammation.

2. A composition for treating an intestinal inflammation in a subject, the composition comprising bacterial hyperswarmers isolated from fecal matter in an amount effective to treat an intestinal inflammation, and yogurt.